PULMONARY BLASTOMYCOSIS

PULMONARY BLASTOMYCOSIS was reported 115 times

PULMONARY BLASTOMYCOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid-based Polyene Antifungal [EPC] 7 0.0005
1 Echinocandin Antifungal [EPC] 3 0.0004
2 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
3 Lipopeptide Antibacterial [EPC] 2 0.0002
4 Bismuth [EPC] 1 0.0002
5 Polyene Antifungal [EPC] 7 0.0002
6 Antimetabolite Immunosuppressant [EPC] 3 0.0001
7 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
8 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
9 Calcineurin Inhibitor Immunosuppressant [EPC] 13 0.0001
10 Proteasome Inhibitor [EPC] 10 0.0001
11 Purine Antimetabolite [EPC] 7 0.0001
12 Corticosteroid [EPC] 89 0.0001
13 Azole Antifungal [EPC] 7 0.0000
14 Alkylating Drug [EPC] 9 0.0000
15 CD20-directed Cytolytic Antibody [EPC] 10 0.0000
16 Nucleoside Metabolic Inhibitor [EPC] 8 0.0000
17 Interleukin-12 Antagonist [EPC] 2 0.0000
18 Thalidomide Analog [EPC] 10 0.0000
19 Interleukin-23 Antagonist [EPC] 2 0.0000
20 Macrolide Antimicrobial [EPC] 1 0.0000
21 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
22 Tetracycline-class Drug [EPC] 1 0.0000
23 Catecholamine [EPC] 1 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
25 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
26 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
27 Nonsteroidal Anti-inflammatory Drug [EPC] 11 0.0000
28 Sulfonylurea [EPC] 1 0.0000
29 Janus Kinase Inhibitor [EPC] 1 0.0000
30 Opioid Agonist [EPC] 1 0.0000
31 Factor Xa Inhibitor [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
33 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 1 0.0000
35 Benzodiazepine [EPC] 1 0.0000